ConductScience.org, home

Comparison · NCT04792970-sae

Talc Instilled Via Tunneled Pleural Catheter Combined With Standard Daily Drainage vs Standard Daily Drainage: serious adverse events

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Talc Instilled Via Tunneled Pleural Catheter Combined With Standard Daily Drainage vs Standard Daily Drainage: serious adverse events. Trial comparisons, record NCT04792970-sae. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT04792970-sae

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.50.09450.905wilson
Risk in group 20.50.09450.905wilson
Risk difference, group 1 minus group 20-0.5730.573newcombe hybrid score
Risk ratio, group 1 over group 210.1417.1log
Odds ratio, group 1 over group 210.019850.4log
Number needed to harmfrom the risk difference intervalthe two groups' risks are equal

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Talc Instilled Via Tunneled Pleural Catheter Combined With Standard Daily Drainage
This arm consists of eligible participants who are randomized to the Talc arm and would receive Talc therapy instilled into the pleural catheter.~Talc: All patients randomized to the Talc arm will receive Talc therapy through the pleural catheter.
12EG000
Group 2Standard Daily DrainageThis arm consists of eligible participants who are randomized to control group and would not receive any intervention.12EG001

Harm

What it counts
Total, serious adverse events
Time frame
1 year

Source ClinicalTrials.gov

Trial

Title
Randomized Controlled Trial of Talc Instillation In Addition To Daily Drainage Through a Tunneled Pleural Catheter to Improve Rates of Outpatient Pleurodesis in Patients With Malignant Pleural Effusion
NCT number
NCT04792970
Phases
PHASE4
Conditions
Malignant Pleural Effusion
Interventions
Talc
Lead sponsor
Duke University
Results first posted
2023-09-28

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT04792970-sae